Talasaz AmirAli: insider trades.
Talasaz AmirAli reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($6.3M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Talasaz AmirAli
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Guardant Health, Inc. (GH) | Director, Officer · Co-Chief Executive Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Guardant Health, Inc. | S | 20,888 | $169.16 | 45,089 | Form 4 |
| 2026-08-21 | Guardant Health, Inc. | S | 9,023 | $168.2 | 65,977 | Form 4 |
| 2026-08-21 | Guardant Health, Inc. | S | 7,589 | $170.29 | 37,500 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | G | 75,000 | $0 | 75,000 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | G | 75,000 | $0 | 1,824,351 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | F | 17,086 | $170.77 | 1,899,351 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 9,715 | $0 | 1,916,437 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 23,997 | $0 | 1,906,722 | Form 4 |
| 2026-06-30 | Guardant Health, Inc. | M | 2,817 | $0 | 1,884,153 | Form 4 |
| 2026-06-30 | Guardant Health, Inc. | F | 1,428 | $150.03 | 1,882,725 | Form 4 |
Questions
What stock did Talasaz AmirAli buy or sell?
Talasaz AmirAli reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($6.3M), across 1 company.
Is Talasaz AmirAli the same person as other filers with this name?
This page covers SEC CIK 1753159 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/talasaz-amirali-1753159.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.